We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine

Product News   Jun 22, 2011

 
FDA Approves Immunovaccine's Application for a Phase I/II Clinical Trial for an Ovarian Cancer Vaccine
FURTHER INFORMATION
 
 
 

Related Product News

Repositive Unveils Molecular Search Functionality for Its Cancer Models Platform

Product News

Repositive has unveiled molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery.

READ MORE

Advances in Bavarian Nordic’s Cancer Immunotherapy Platform

Product News

A paper discussing recent preclinical advances of Bavarian Nordic’s novel cancer immunotherapy platform has been published in Nature Communications.

READ MORE

Enrichment of Human Carcinoma Cells for Sensitive Molecular Analysis

Product News

The FFPE Tissue Dissociation Kit is designed to enhance the sensitivity of molecular analysis of carcinoma tumor cells.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE